Frontiers in oncology.

Effect of different treatment modalities on the prognosis of patients with stage IIIC cervical cancer. Xiaoman Su. Jiazhen Huang. Ning Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1405778. Highlights research in carcinogenesis and tumor progression, bridging the gap between basic research and clinical applications to advance diagnosis ...Another fast-growing research area in radiation oncology is radiomics which uses data-characterization algorithms to extract features from radiological images, detect patterns, and uncover cancer characteristics as images contain much more information than perceived by the imaging interpreter or the clinician.2.1 Characterization of Resistance in Cancer. Drug resistance in cancer is an intimate occurrence that results when cancer becomes tolerant of pharmaceutical treatment ().An extensive range of factors contributes to the development of resistance against anticancer drugs, including genetic mutations, altered epigenetics, enhanced drug efflux, …Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.Nov 15, 2022 ... "Structure Matters: A Call to Action," presented by Robert A. Winn, MD, Director and Lipman Chair in Oncology, VCU Massey Cancer Center.

Oncology. Oncology is a specialized field of medicine that focuses on the prevention, diagnosis, and treatment of various types of cancer. Our Research Topics explore key advancements in oncology which have led to significant breakthroughs in cancer care, such as targeted therapies, immunotherapy, and precision medicine.Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …

Epigenetic and Metabolic Regulators of Breast Carcinogenesis. Iman Mamdouh Talaat. Maha Mohamed Saber-Ayad. Hauke Busch. Noha Mousaad Elemam. 21,657 views. 14 articles. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast ...Frontiers in Oncology ... Sodium-Glucose Co-Transporter 2 Inhibitors May Change the Development of Urinary Tract and Hematological Malignancies as Compared With ...

See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.3 days ago · See all (43) Learn more about Research Topics. This section explores molecular and clinical characteristics of a broad group of malignancies with special interest on the biology and therapeutic strategies for head and neck cancer subtypes. Frontier Communications is one of the largest telecommunications companies in the United States, providing high-speed internet, phone, and TV services to millions of customers acro...Frontiers in Cardiovascular Medicine: Rising Stars 2023. Kazufumi Nakamura. Ricardo Sanz-Ruiz. David Marti. Manuel M Mazo. Diana S Nascimento. Elisa Avolio. Olaf Bergmann. Rajesh Katare.

Mechanobiology in oncology: basic concepts and clinical prospects. Michelle B. Chen 1† Yousef Javanmardi 2† Somayeh Shahreza 2 Bianca Serwinski 2,3,4 Amir Aref 5 Boris Djordjevic 2,3 Emad Moeendarbary 1,2 *. 1 Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.

mohammad athar. University of Alabama at Birmingham. Birmingham, United States. Specialty Chief Editor. Skin Cancer.

Frontier Airlines is a popular low-cost carrier that offers affordable flights to various destinations across the United States. If you are planning to fly with Frontier, it’s impo...The main constituents of the ECS are the classical cannabinoid (CB) receptors, such as CB 1 and CB 2, their endogenous ligands (endocannabinoids), and the endocannabinoids’ synthesizing and degrading enzymes. The role of the ECS in cancer is still unclear and its effects often depend on the tumor entity and the expression levels of …The Potential of Photoacoustic Imaging in Radiation Oncology. Thierry L. Lefebvre 1,2 Emma Brown 1,2 Lina Hacker 1,2 Thomas Else 1,2 Mariam-Eleni Oraiopoulou 1,2 Michal R. Tomaszewski 3† Rajesh Jena 4 Sarah E. Bohndiek 1,2*. 1 Department of Physics, University of Cambridge, Cambridge, United Kingdom. 2 Cancer Research UK …1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …Nevertheless, according to the Associazione Italiana di Oncologia Medica (AIOM), the European Society for Medical Oncology (ESMO), and the National Comprehensive Cancer Network ® (NCCN) guidelines, neoadjuvant chemotherapy is an established treatment that improves oncological outcomes in locally advanced …

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ib non-small-cell lung cancer: calgb 9633 with the cancer and leukemia group B, radiation therapy oncology group, and north central cancer treatment group study groups.Female breast cancer (BC) has surpassed lung cancer and today it is the most diagnosed type of cancer (2.3 million new cancer cases, representing 11.7% of all cancer cases). In terms of mortality, it ranks in 5 th place, with 685,000 deaths in 2020. For women, BC represents 1 in 4 cancer cases and accounts for 1 in 6 cancer deaths ( 1 ).Scope. This section aims to publish significant clinical and basic research findings on all aspects related to hematologic malignancies, including the areas of acute and chronic leukemias, lymphomas and Hodgkin’s disease, plasma cell disorders, and stem cell transplantation. Our ultimate goal is to accelerate the communication in the field ... Treatment effect on contrast-enhanced tumor (CET) was evaluated according to the response assessment in neuro-oncology (RANO) criteria for clinical trials . In addition, an automated software-based method developed in house was used to objectively calculate the CET volume (see below and Supplementary Appendix ). Institute of Molecular Pathology Biomarkers, University of Extremadura. Cáceres, Spain. Specialty Chief Editor. Pharmacogenetics and Pharmacogenomics.They offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: 1) Different schools of thought or controversies, 2) Current research gaps, 3) Potential future developments in the field.

They should provide the following: 1) Discuss current advances and future directions, 2) Clear presentation of the authors’ perspective, 3) Accurate presentation and citations of other authors’ work, 4) May include original data as well as personal insights and opinions.

Apr 23, 2024 ... Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Rong Wang ...Molecular Landscapes of Human Papillomavirus-Related Squamous Cell Carcinoma. Jinhui Liu. Jianguang Ji. Liang Zhou. 12,031 views. 6 articles. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Frontiers has a community retraction protocol in place to retract papers where serious concerns have been raised and validated by the community that warrant retraction, including ethical concerns, honest errors or scientific misconduct. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.Introduction. Glioma is the most common neuroepithelial tumor of the cerebral nervous system ().Ki-67 labeling index (LI) is a nuclear antigen expressed only by proliferating cells ().Previous studies showed that Ki-67 LI was one of the vital biological behavior biomarkers in glioma and correlated with glioma grading and prognosis (3, …Gostaríamos de exibir a descriçãoaqui, mas o site que você está não nos permite.Research Topics. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.4 Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia 5 Telethon Kids Institute, University of Western Australia, West Perth, WA, Australia Chemotherapy has historically been the mainstay of cancer treatment, but our understanding of what drives a successful therapeutic response remains limited.Frontiers | Registration - Frontiers | Peer Reviewed ArticlesQuan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.

Frontiers

In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 …

3 days ago · James L. Gulley. Frontiers in Oncology. doi 10.3389/fonc.2024.1376622. 218 views. Driving the fast-moving field of immunosurveillance, tumor escape and cancer immunotherapy by hosting research, discussion and new hypotheses. Biological Functions and Therapeutic Potential of SRY related high mobility group box 5 (SOX5) in human cancer. Xue juan Di. Wanfang Xiang. Ming-qin Cai. Xiaoyun Lv. Frontiers in Oncology. doi 10.3389/fonc.2024.1332148. Explores research into the molecular and cellular mechanisms of carcinogenesis and cancer progression.The association between objective imaging response and first line immune checkpoint inhibitor (ICI) therapy regimes in advanced melanoma remains …Background aims: The field of cell and gene therapy in oncology has moved rapidly since 2017 when the first cell and gene therapies, Kymriah followed by Yescarta, were …harry burke. Uniformed Services University of the Health Sciences. Bethesda, United States. Associate Editor. Cancer Molecular Targets and Therapeutics. Part of a multidisciplinary journal, this section explores targetable intervenients in cancer signaling pathways and their application in drug development and therapeutics.3. Segmentation: To achieve reliable radiomic models in oncology, robustly and precisely delineating lesions is essential. However, traditional manual segmentation usually takes a very long time to perform, generates interobserver variability, and requires the involvement of experienced radiologists for analysis.How we publish. Frontiers' approach to publishing is driven by the principle of placing publishing back into the hands of researchers, enabled by scalable technology. This means we distribute editorial responsibility to the editorial board who take acceptance or rejection decisions and have the independence to shape the direction of research.Genetics, genomics and RNA-based biomarker development. Whole genome studies and focused studies of individual genes contributing to cancer molecular pathways. New rationales for bringing molecular genetic findings to the clinical oncology space. Submissions not in scope for this specialty include: Those consisting solely of …Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Quan Yuan. Yunmei Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1325362. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.

In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 …Frontiers in Oncology publishes rigorously peer-reviewed research across the entire field of cancer research. Field Chief Editor Giuseppe Giaccone at Georgetown University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and …Frontiers in Oncology is composed of the following specialties: Cancer Endocrinology . Cancer Epidemiology and Prevention . Cancer Genetics . Cancer Imaging and Diagnosis …Instagram:https://instagram. animated picturesread me tocompton street legendreceipts generator michael kattan. Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University. Cleveland, United States. Specialty Chief Editor. Genitourinary Oncology.A future TCR-T therapy encompassing multiple innovations is illustrated in Figure 15, as an example of the driving force in the E2E Platform applied across multiple modules to support the goal of developing differentiated, best-in-class TCR-T therapies as new and better treatment options for cancer patients. petrol expense calculatorfirst financial federal credit union Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology. bwi to paris Aram Boada. Anna Martinez-Cardús. Alan Chu. Zongwen Liu. Jose Luis Manzano. Frontiers in Oncology. doi 10.3389/fonc.2024.1322116. 783 views. Part of a multidisciplinary journal, this section expands our understanding of molecular and cellular mechanisms involved in skin cancer progression.Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health …Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ...